Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSulfur burps on tirzepatide are a real and recognised side effect — the rotten-egg smell comes from hydrogen sulphide gas produced when stomach contents sit longer than usual because the medicine slows gastric emptying. They tend to be most noticeable in the first few weeks at a new dose and, for most people, ease considerably as the body adjusts. Tirzepatide is a prescription-only medicine; a clinician assesses whether it is suitable for you before it can be prescribed. The full side-effect picture for Mounjaro covers the broader GI profile, but sulphur burps specifically deserve their own explanation because the question comes up often and the reassurance is genuinely useful.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common worry our prescribers hear is that the smell means the medicine is not working properly, or that it signals a serious problem. It does not. Sulfur burps are a predictable downstream effect of how tirzepatide works. As a dual GIP and GLP-1 receptor agonist, tirzepatide slows the rate at which the stomach empties into the small intestine — a mechanism that contributes to the feeling of fullness and reduced appetite that makes it effective for weight management. The slower transit gives naturally occurring gut bacteria extra time to ferment protein and other sulphur-containing compounds, and hydrogen sulphide is the by-product. The NHS explains this gastric-emptying mechanism as part of how tirzepatide acts on the body. So the smell is unpleasant, sometimes embarrassing, occasionally quite antisocial, but it is a physiological consequence of the medicine doing what it is designed to do, not evidence of a complication. Knowing that tends to make it considerably easier to sit with.
It is also worth noting that not everyone gets them. Some people complete a full titration from 2.5mg through to their maintenance dose and barely notice. Others find the first few weeks at each new strength are reliably gassy. Individual gut microbiome composition, diet and eating speed all play a part.
Timing matters here. For most people, tirzepatide sulfur burps follow a recognisable pattern: they arrive a day or two after starting a new dose or moving up to the next strength, peak over a few days, then gradually fade as gastric emptying adapts. The body's tolerance to slower emptying does build over time. By the time someone has been stable on a given dose for three or four weeks, the GI side effects (including the sulphur-y burping) are often much less intrusive than they were in week one. The broader picture of burping on tirzepatide covers how other forms of belching fit into this same pattern. If symptoms remain severe or are getting worse after two to three weeks at a stable dose, that conversation belongs with the prescriber rather than on a forum.
The MHRA's guidance on GLP-1 medicines flags that significant, persistent stomach pain (particularly pain that radiates toward the back) warrants urgent medical attention as it can indicate pancreatitis, which is a rare but serious side effect distinct from ordinary gas. Sulphur burps alone, without significant abdominal pain, are not in that category. But the distinction matters and is worth knowing. You can report any suspected side effect through the MHRA Yellow Card scheme.
Dietary adjustment is by far the most effective lever most people can pull. Foods high in sulphur (eggs, red meat, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, onions) provide more substrate for hydrogen sulphide production. Reducing them temporarily, particularly in the days around a dose step-up, makes a noticeable difference for many people. Eating more slowly, keeping portions smaller and avoiding very high-fat meals all reduce how hard the slowed stomach has to work. Fat specifically delays gastric emptying further on top of what tirzepatide is already doing, so a greasy meal on injection day can compound the problem considerably. Staying well-hydrated helps keep things moving through the gut. Guidance on managing sulphur burps on Mounjaro goes into the practical day-to-day detail if you want a more structured approach.
Some people find that timing their weekly injection around their diary helps, knowing that days two and three after an injection tend to be windier, they plan accordingly. It is a small thing, but it puts a bit of control back. For context on the wider GI side effects that sometimes accompany this, the gas and bloating page covers the overlap. If you are also wondering about the sulphur burp experience specifically as described across the tirzepatide literature, the sulphur burps and tirzepatide page addresses the spelling variant and rounds up what the clinical record says.
One more detail worth knowing: when your Mounjaro pen arrives by tracked DPD delivery, in a plain, unbranded box, it comes ready to store in the fridge. Keeping the pen refrigerated until use and injecting at the same day each week keeps the dose as consistent as possible, which in turn helps keep side-effect patterns predictable rather than chaotic. Erratic dosing can trigger GI symptoms all over again as though you were restarting. Consistency is one of the simplest tools available.
If cost or access to treatment is part of your thinking, the weight-loss treatment overview sets out what private prescription treatment involves. And if you are weighing up whether tirzepatide is the right option for you at all, the Mounjaro information page covers the evidence, licensing and eligibility in full, a useful read before any consultation. The NHS medicines information for tirzepatide also summarises the common side effects, including gastrointestinal ones, in plain language.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.